NCT06999070

Brief Summary

The precise etiology of post-spinal anesthesia shivering (PSAS) is not fully understood. The incidence ranges between 20 to 80%. Heat loss, reduced sympathetic tone and pyrogen release are termed as the main causes of intra/postoperative shivering. The redistribution of heat from the core to the periphery of the body is facilitated by the vasodilatation associated with neuraxial anesthesia. Shivering causes tachycardia, lactic acidosis, hyperalgesia at the site of surgery, releases catecholamines, increases oxygen demand, and increases the risk of hypoxemia. \[1\]\[3\] The most common causes of shivering include fever, shivering with spinal anesthesia movement disorders, post-anesthetic shivering, fear, excitement, stress, tremors, low blood sugar, anxiety, and shivering. Shivering with spinal anesthesia is an involuntary, oscillatory muscular activity that significantly increases metabolic heat production, potentially reaching up to 600% above the basal metabolic level. Post-spinal shivering is one of the main sources of discomfort for patients recovering from surgery. Furthermore, it worsens wound pain and impedes electrocardiographic monitoring. Prophylactic intravenous administration of dexamethasone has been currently used for controlling intra-operative and post spinal anesthesia shivering. Dexamethasone's anti-inflammatory effects may thereby lessen post-anesthesia shivering by reducing the gradient between skin and core body temperatures.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
150

participants targeted

Target at P75+ for not_applicable

Timeline
10mo left

Started May 2025

Typical duration for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress56%
May 2025Mar 2027

Study Start

First participant enrolled

May 1, 2025

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 5, 2025

Completed
26 days until next milestone

First Posted

Study publicly available on registry

May 31, 2025

Completed
1.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2026

Expected
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2027

Last Updated

May 31, 2025

Status Verified

May 1, 2025

Enrollment Period

1.6 years

First QC Date

May 5, 2025

Last Update Submit

May 30, 2025

Conditions

Keywords

DexamethasonePost spinal anesthesia shivering

Outcome Measures

Primary Outcomes (1)

  • severity of PSAS

    Bedside Shivering Assessment Scale (BSAS) was used to grade the severity: Grade 1 (zero points): No shivering Grade 2 (1 point): mild shivering that is limited to the neck and thorax may not be detected and may only be detected by palpation or as an artefact on ECG Grade 3 (2 points): Moderate: Intermittent upper extremity involvement plus/minus thorax Grade 4 (3 points): Severe: prolonged trembling of the upper or lower extremities or widespread shivering.

    60 minutes after operation

Study Arms (2)

Group A

ACTIVE COMPARATOR

Patients will take 0.1 mg/kg dexamethasone iv on incidence of Shivering after spinal anaethesia

Drug: Dexamethasone 0.1mg/kg

Group B

ACTIVE COMPARATOR

patients will take Dexamethasone 0.3 mg/kg intravenously injected to the patients after the detection of shivering

Drug: Dexamethasone 0.3mg/kg

Interventions

On incidence of Shivering after spinal anaethesia

Group A

On incidence of Shivering after spinal anaethesia

Group B

Eligibility Criteria

Age21 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)

You may qualify if:

  • ASA physical status I-II.
  • Both sexes.
  • Age: 21-55 years old.
  • Scheduled for lower limb orthopedic surgery.
  • BMI less than 35 kg/m2.

You may not qualify if:

  • ASA physical status more than II.
  • History of corticosteroid therapy or allergic reaction to any of the medication used in the study
  • Patients with cognitive impairment.
  • Pregnancy.
  • Basal body temperatures of more than 38° or less than 36° C.
  • BMI more than 35 kg/m2.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Links

MeSH Terms

Interventions

Dexamethasone

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
FACTORIAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
A randomized, comparative study of different doses of intravenous dexamethasone for management of post spinal anesthesia shivering in lower limb orthopedic surgeries

Study Record Dates

First Submitted

May 5, 2025

First Posted

May 31, 2025

Study Start

May 1, 2025

Primary Completion (Estimated)

December 1, 2026

Study Completion (Estimated)

March 1, 2027

Last Updated

May 31, 2025

Record last verified: 2025-05